CTNM CAPEX

Annual CAPEX

$414.00 K
NaN%

December 31, 2023

Summary

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

CTNM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

25.74%
CTNM annual capital expenditures is higher than 25.74% of companies in Healthcare sector

High & Low

All-time High

$414.00 K
CTNM annual capital expenditures is currently at an all-time high

3-Year Low

$414.00 K
CTNM annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CTNM previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
CTNM next annual earnings announcement is scheduled for Feb 28, 2025

OtherCTNMcash flowmetrics:

Annual FCF

$18.93 M
CTNM annual free cash flow is $18.93 million

Annual CFO

$19.35 M
CTNM annual cash flow from operations is $19.35 million

Annual CFI

-$65.57 M
CTNM annual cash flow from investing activities is -$65.57 million

Annual CFF

$56.18 M
CTNM annual cash flow from financing activities is $56.18 million

Quarterly CAPEX

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CTNM Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$31.00 K
CTNM quarterly capital expenditures is currently at an all-time high

3-Year Low

$31.00 K
CTNM quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CTNM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
CTNM next earnings announcement is scheduled for Feb 28, 2025

OtherCTNMcash flowmetrics:

Quarterly FCF

-$6.25 M
CTNM quarterly free cash flow is -$6.25 million

Quarterly CFO

-$6.17 M
CTNM quarterly cash flow from operations is -$6.17 million

Quarterly CFI

-$30.18 M
CTNM quarterly cash flow from investing activities is -$30.18 million

Quarterly CFF

$13.00 K
CTNM quarterly cash flow from financing activities is $13.00 thousand

TTM CAPEX

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CTNM TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$31.00 K
CTNM TTM capital expenditures is currently at an all-time high

3-Year Low

$31.00 K
CTNM TTM capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CTNM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
CTNM next earnings announcement is scheduled for Feb 28, 2025

OtherCTNMcash flowmetrics:

TTM FCF

-$34.00 M
CTNM TTM free cash flow is -$34.00 million

TTM CFO

-$33.35 M
CTNM TTM cash flow from operations is -$33.35 million

TTM CFI

-$51.32 M
CTNM TTM cash flow from investing activities is -$51.32 million

TTM CFF

$108.04 M
CTNM TTM cash flow from financing activities is $108.04 million

CTNM CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

CTNM CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low
5 y5-yearat highat low
alltimeall timeat highat low

Contineum Therapeutics Class A CAPEX History

DateAnnualQuarterlyTTM
Dec 2023
$414.00 K
-
-
DateAnnualQuarterlyTTM
Jun 2023
-
$31.00 K
$31.00 K

FAQ

  • What is Contineum Therapeutics Class A annual capital expenditures?
  • What is the all time high annual CAPEX for Contineum Therapeutics Class A?
  • What is the all time high quarterly CAPEX for Contineum Therapeutics Class A?
  • What is the all time high TTM CAPEX for Contineum Therapeutics Class A?

What is Contineum Therapeutics Class A annual capital expenditures?

The current annual CAPEX of CTNM is $414.00 K

What is the all time high annual CAPEX for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high annual capital expenditures is $414.00 K

What is the all time high quarterly CAPEX for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high quarterly capital expenditures is $31.00 K

What is the all time high TTM CAPEX for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high TTM capital expenditures is $31.00 K